GILD Description — Gilead Sciences Inc

Gilead Sciences is a biopharmaceutical company, focusing on medicines to prevent and treat diseases, including HIV, viral hepatitis and cancer. Co.'s products include: Biktarvy®, which is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), an injection for intravenous use, which is a nucleotide analog RNA polymerase inhibitor indicated for certain patients for the treatment of COVID-19 requiring hospitalization; and Epclusa®, which is an oral formulation of a once-daily single tablet regimen of sofosbuvir and velpatasvir for the treatment of chronic hepatitis C virus (HCV) infection in adults and certain pediatric patients.

Company Name: 
Gilead Sciences Inc
Number of ETFs Holding GILD: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   GILD Weight   GILD Amount 
 VTI   0.25%   $3,143,080,442         
 VOO   0.30%   $2,372,459,845         
 QQQ   0.79%   $1,333,707,556         
 SPY   0.30%   $1,107,225,858         
 VTV   0.61%   $906,761,187         
 IVV   0.30%   $906,649,479         
 XLV   2.11%   $807,182,247         
 VYM   0.74%   $452,080,642         
 USMV   1.48%   $419,247,375         
 VHT   1.75%   $340,173,330         
List of all 138 ETFs holding GILD »
Quotes delayed 20 minutes

Email EnvelopeFree GILD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (2.82 out of 4)
17th percentile
(ranked lower than approx. 83% of all stocks covered)

Analysts Forecast:
GILD Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding GILD | Gilead Sciences Inc | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.